This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Prometic Biosciences Inc.. Active years: 2010-2011.
Company Filing History:
Years Active: 2010-2011
Title: Nicole Wilb: Innovator in Autoimmune Disease Treatment
Introduction
Nicole Wilb is a prominent inventor based in Montreal, Canada. She has made significant contributions to the field of autoimmune disease treatment through her innovative research and patented inventions. With a focus on developing compounds that can effectively treat various autoimmune conditions, Wilb has established herself as a key figure in this important area of medical science.
Latest Patents
Nicole Wilb holds 2 patents that showcase her groundbreaking work. Her latest patents include "Purine derivatives and their use for treatment of autoimmune diseases," which describes compounds useful in treating autoimmune diseases. Another notable patent is "Triazine dimers for the treatment of autoimmune diseases," which details compounds containing two mono- or disubstituted triazine rings linked by an organic linker. These compounds are designed to treat conditions such as rheumatoid arthritis, systemic lupus erythematosus (SLE), idiopathic thrombocytopenia (ITP), glomerulonephritis, and vasculitis. Additionally, her inventions aim to reduce drug toxicity often associated with traditional therapies for autoimmune diseases.
Career Highlights
Throughout her career, Nicole Wilb has worked with notable companies in the biotechnology sector, including Prometic Biosciences Inc. and Prometic Pharma Smt Limited. Her work in these organizations has allowed her to advance her research and contribute to the development of innovative treatments for autoimmune diseases.
Collaborations
Nicole has collaborated with esteemed colleagues such as Daniel Fortin and Boulos Zacharie. These partnerships have further enriched her research and expanded the impact of her inventions in the medical community.
Conclusion
Nicole Wilb's contributions to the field of autoimmune disease treatment through her patents and collaborations highlight her dedication to improving patient outcomes. Her innovative work continues to pave the way for new therapeutic options in the fight against autoimmune diseases.